These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29083341)

  • 1. A case of refractary epilepsy and related pain due to dysmenorrhea solved with loading dose of lacosamide: clinical and neurophysiological correlates.
    Marchitto N; Ceratti U; Dalmaso S; Raimondi G
    Acta Biomed; 2017 Oct; 88(3):334-336. PubMed ID: 29083341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
    Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
    Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacosamide for epileptic seizures in patients with co-morbidities and unusual presentations of epilepsy.
    Sierra-Marcos A; Bermejo PE; Manso Calderón R; Gutiérrez-Álvarez AM; Jiménez Corral C; Sagarra Mur D
    CNS Drugs; 2011 Dec; 25 Suppl 1():17-26. PubMed ID: 22141348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex.
    Geffrey AL; Belt OD; Paolini JL; Thiele EA
    Epilepsy Res; 2015 May; 112():72-5. PubMed ID: 25847341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
    Rastogi RG; Ng YT
    J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide in patients with pharmacoresistant epilepsy.
    Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
    Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.
    Brenner J; Majoie HJM; van Beek S; Carpay JA
    Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide use in refractory idiopathic primary generalized epilepsy.
    Zangaladze A; Skidmore C
    Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
    Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
    Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
    Paquette V; Culley C; Greanya ED; Ensom MH
    Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
    Kissin MY; Bondarenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.